Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis - Related Studies

Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis (OPTIMA)

This study has been completed.

Study NCT00420927 Information provided by Abbott

First Received on January 9, 2007. Last Updated on April 16, 2012 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Rheumatoid Arthritis

Additional conditions recognized in this trial

Arthritis
Arthritis, Rheumatoid

More general conditions related to this trial

Interventions listed in this trial

adalimumab
methotrexate
placebo

More general drug interventions related to this trial

Sponsors listed in this trial

Abbott